| Project number | 419-17-GK |
| name of the project | “Development and organization of production of Ros-bengal antigen for plate agglutination reaction for diagnostics of animal brucellosis” |
| Applicant | Kazakh Scientific and Research Veterinary Institute” Limited Liability Partnership |
| Grantee | Limited Liability Partnership “Kazakh Scientific Research Veterinary Institute” |
| Private Partner | |
| Implementation period | 2017-2020 |
| Place of sale (city/region) | Almaty |
| Industry | Agribusiness and processing of agricultural raw materials |
| Objective of the project | Development and organization of production
rose bengal antigen for the platelet reaction agglutination reaction for the diagnosis of animal brucellosis OIE standard. |
| Project Description | Antigen for serological agglutination reaction
The aim of this project is to develop new technologies in the field of veterinary medicine and biotechnology. technologies in veterinary medicine and biotechnology, namely namely, the creation of a competitive product – the rose bengal antigen. This project is aimed at developing new technologies in veterinary medicine and biotechnology – production of a competitive product – the Rose Bengal antigen. It has a clear advantage over existing Kazakhstan preparations for the diagnosis of brucellosis. Kazakhstan’s existing brucellosis diagnostic preparations. The implementation of the project will make it possible to produce The project will make it possible to produce a competitive product and obtain a product so vital for veterinary medicine The project will make it possible to produce a competitive product and obtain a product so important and necessary for veterinary medicine, which is so important for veterinary medicine is not currently produced in the Republic of Kazakhstan. |
| Website | https://www.kaz-nivi.kz/ |
| List of products sold with prices | Rose bengal antigen 40 000 tg/litre |
| Project team (full name) | Abutalip A. Myrzaliea A.J. Baramova Sh.A. Sultanov A.A. Ospanov E.K. Tusiphanuly 0. Charyphan D. |